Artiva Biotherapeutics attributed one of the fatalities to a drug used to prepare patients for cell therapy and not to the ...
The cost of waiting is not evenly distributed. Rural and critical access hospitals report under 50 percent adoption of even ...
Corxel Pharmaceuticals is catching up to others with oral GLP-1 obesity drugs, but the biotech claims its small molecule ...
Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares ...
Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 ...
In addition to a packed conference agenda and tours of the Pegasus Park healthcare and life science innovation hub in Dallas, ...
CMS has introduced uncertainty about whether Medicare will participate in that modernization or preserve the old system under a different name. The consequences extend far beyond billing ...
The MATCH IT Act aims to reduce patient matching errors. But a model used by vital records systems could provide a better ...
CareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy ...
MedTech Conference panelists cited inflammation research, listening to women, clinical trial representation and investment as ...
Throwing more money at SDoH programs isn’t going to magically fix them. Instead, plans should be focusing on building out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results